G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2004
11/25/2004	WO2004053454A8 Methods for detecting invasion of a cell
11/25/2004	WO2004053063A3 Molecular determinants of myeloma bone disease and uses thereof
11/25/2004	WO2004045364A3 Methods of detecting ovarian neoplasia
11/25/2004	WO2004038036A3 Methods of assaying for modulators of the inflammatory process using components of the ubiquitin ligation cascade
11/25/2004	WO2004036208A3 Method and device for determining the sheen of rice
11/25/2004	WO2004027378A3 Luminescence-based methods and probes for measuring cytochrome p450 activity
11/25/2004	WO2004025268A3 Optical biosensors and methods of use thereof
11/25/2004	WO2004009786A3 Modulators of leukocyte activation, bic compositions and methods of use
11/25/2004	WO2003100078A3 Common ligand universal enzyme and compositions for use therein
11/25/2004	WO2003086280A3 Immunostimulatory g,u-containing oligoribonucleotides
11/25/2004	WO2003081509A3 DATA MINING OF SNP DATABASES FOR THE SELECTION OF INTRAGENIC SNPs
11/25/2004	WO2003078652A3 Modification of selectivity for sensing for nanostructure device arrays
11/25/2004	WO2003074662A3 SCDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
11/25/2004	WO2003021229A3 Diagnostic and prognostic tests
11/25/2004	WO2002086097A8 Methods for identifying the target of a compound which inhibits cellular proliferation
11/25/2004	WO2002082264A3 A font for displaying genetic information
11/25/2004	WO2002078524A3 Translational profiling
11/25/2004	WO2002019602A3 Statistical modeling to analyze large data arrays
11/25/2004	US20040237127 Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
11/25/2004	US20040236603 System of analyzing complex mixtures of biological and other fluids to identify biological state information
11/25/2004	US20040236555 Target ligand generation
11/25/2004	US20040236520 Method for analysing samples of biomolecules in an array
11/25/2004	US20040236519 Libraries of confomationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same
11/25/2004	US20040236517 Selection of target sites for antisense attack of rna
11/25/2004	US20040236516 Bioinformatics based system for assessing a condition of a performance animal by analysing nucleic acid expression
11/25/2004	US20040236514 Controlling distribution of epitopes in polypeptide sequences
11/25/2004	US20040236512 Method and apparatus for chemometric estimations of fluid density, viscosity, dielectric constant, and resistivity from mechanical resonator data
11/25/2004	US20040236250 Method and device for sampling and analyzing interstitial fluid and whole blood samples
11/25/2004	US20040236199 Method and apparatus for remote blood alcohol monitoring
11/25/2004	US20040236093 Using chimeric dendritic cells comprising viral epitopes to generate vaccines to prevent and treat viral diseases
11/25/2004	US20040236091 Nucleotide sequences coding major histocompatibility complex proteins for use in diagnosis, prevention and treatment of cell proliferative disorders
11/25/2004	US20040236087 Moraxella(branhamella) catarrhalis antigens
11/25/2004	US20040236081 Immunoglobulin which binds interleukkin-1bconverting enzyme for use in diagnosis, treatment and prevention of autoimmune, neurodegenerative and cell proliferative disorders
11/25/2004	US20040236077 Capable of specifically reacting with the N-terminal region of a partial peptide in a polypeptide with a specific amino acid sequence, used for diagnosis of pregnancy
11/25/2004	US20040236076 Polyclonal IgY compound from eggs of transgenic SPF-chickens with constant regions of human IgG and additionally consist of at least one signal and/or active agent and/or booster molecule; for treating noninfectious inflammations, infectious diseases, clotting disorders, autoimmune diseases and cancer
11/25/2004	US20040236072 Immunogenic polynucleotides, polypeptides, and antibodies used for detecting, immunizing against, and reducing beta-hemolytic streptococcal infection
11/25/2004	US20040235856 Treatment of incontinence
11/25/2004	US20040235813 Compounds that inhibit hsp90 and stimulate hsp70 and hsp40, useful in the prevention or treatment of diseases associated with protein aggregation and amyloid formation
11/25/2004	US20040235776 Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer
11/25/2004	US20040235768 Human platelet F11 receptor
11/25/2004	US20040235766 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication
11/25/2004	US20040235740 Administered as antitumor, antimetastasis, anticarcinogenic and/or wound healing agent; tissue regeneration
11/25/2004	US20040235735 Gene expression of cells; genetic engineering using tripeptides; antiinflammatory agents; apoptosis;medical diagnosis
11/25/2004	US20040235729 Complementarity-determining region; monoclonal antibodies; antiidiotypic antibodies; autoantibodies; heavy chains; light chains; polypeptides; amino acid sequences; DNA; carriers; use for treatment of systemic lupus erythematosus in humans
11/25/2004	US20040235722 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs
11/25/2004	US20040235717 Suppression of androgen receptor transactivation through new pathways to ar and ar coactivators and repressors
11/25/2004	US20040235706 Fabric softening compositions and methods
11/25/2004	US20040235198 Detector comprising thin film and immobilized peptide domains for use in monitoring antitumor treatments; drug screening
11/25/2004	US20040235197 Process for detecting binding reactions with use of the measurement of the relaxation of the double refraction of magnetic particles
11/25/2004	US20040235196 Method for treating magnetic particles and biological analysis device using magnets
11/25/2004	US20040235195 Methods for measuring and diagnosing endotoxin, sensor therefor, and method for producing and reusing the sensor
11/25/2004	US20040235194 Short turnaround time insulin assay and protocol therefor
11/25/2004	US20040235193 Steroid hormone analysis by mass spectrometry
11/25/2004	US20040235192 Assay device
11/25/2004	US20040235190 Assays for detecting, identifying and/or quantifying contaminants with liposomes
11/25/2004	US20040235189 Improved solid phase assay for detecting preferential particles, infectious antigens, antibodies and auto-antibodies in solution
11/25/2004	US20040235188 Thyroid hormone analysis by mass spectrometry
11/25/2004	US20040235186 Tag molecule with a reactive site for stably associating with a protein, an isotope label, and an anchoring site for anchoring the tag molecule to a solid phase
11/25/2004	US20040235184 measuring the conducting change of a sensor made of complex of poly N,N'-ethylenebis(salicylidenimine) and cobalt through binding of NO (analyte) to the metal ion of the sensor causes the conductivity change
11/25/2004	US20040235183 Using concentration of follicle stimulating hormone in urine to determine impregnation readiness and ovarian reserve
11/25/2004	US20040235182 Adhered membranes retaining porosity and biological activity
11/25/2004	US20040235181 Analyzing liquid feed stream in which a plurality of particles is dispersed via assembling the particles in a configuration in which all the particles lie in the same plane, and processing the assembled particles while they are in that configuration; cytometric analysis of cells, cell fragments or beads
11/25/2004	US20040235180 Method for analyzing a biological sample
11/25/2004	US20040235178 Sample discriminating method
11/25/2004	US20040235163 Comprises regulatory agent which prevents apoptosis and/or cardiac oxidative stress in myocardial tissues; identifying modulators of atp sensitive potassium channels
11/25/2004	US20040235157 Transgenic cell line for use as tools in identification of signal transduction modulators; diagnostic assay comprising enhanced shelf life
11/25/2004	US20040235146 Receptor-ligand systems used for analysis; high throughput assay
11/25/2004	US20040235145 Transdermal assay with magnetic clamp
11/25/2004	US20040235116 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
11/25/2004	US20040235113 18 human secreted proteins
11/25/2004	US20040235102 Comprises adenosine triphosphate binding cassette membrane protein for use in identifying modulator which prevent transport of neurotoxic molecules; treating nervous system disorders
11/25/2004	US20040235094 Regulation of human ptpase-like protein
11/25/2004	US20040235092 Comprises expression vectors coding heterologous protein for use as tools in diagnosis and treatment of cell proliferative, nervous system, inflammatory and autoimmune diseases
11/25/2004	US20040235086 Detection of cellular contaminants in samples of non-living material
11/25/2004	US20040235083 Screening method
11/25/2004	US20040235080 Mixture comprising recombinantly produced horseshoe crab Factor C protein and a surfactant for detection of gram negative bacterial endotoxin; monitoring purity of food and water and drugs
11/25/2004	US20040235078 Kits for screening for blood coagulation disorders
11/25/2004	US20040235076 Immunological analytical method and device for the determination of glycosylated protein
11/25/2004	US20040235075 Rapid immunoassay of anthrax protective antigen in vaccine cultures and bodily fluids by fluorescence polarization
11/25/2004	US20040235073 Using nuclear and lower cytosolic localization of kruppel-like transcription factors to diagnose and prognose viability of individuals with cell proliferative disorders
11/25/2004	US20040235072 Compositions and methods for the therapy and diagnosis of lung cancer
11/25/2004	US20040235071 Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476, 62113, 64316, 12264, 32362, 58198, 2887, 3205, 8557, 9600, 9693, 44867, 53058, 55556, 57658, 2208, 10252, 10302, 14218, 33877, 10317, 10485, 25964, 14815, 1363, 1397, 14827, 21708, 3801, 64698, 2179 or 13249
11/25/2004	US20040235070 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy
11/25/2004	US20040235069 isolated polypeptide have specified sequence which has an activity to cause permeation of ions
11/25/2004	US20040235068 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
11/25/2004	US20040235067 Stain-directed molecular analysis for cancer prognosis and diagnosis
11/25/2004	US20040235066 Using immunoglobulin specific to cancer testis-antigens for use in diagnosis and treatment of cell proliferative diseaes; immunotherapy
11/25/2004	US20040235065 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof
11/25/2004	US20040235064 Peptide complexes comprising reporter fusion which associate through combinations of helical domains to form an antiparallel leucine zipper; protein-protein interaction assays; mimetics
11/25/2004	US20040235063 Exposing mammalian cells to plant extract, lyse tested mammalian cells and compare pattern of phosphorylated proteins to pattern of phosphorylated proteins in control cells, evaluate for bioactivity; identifying medicinal plant components
11/25/2004	US20040235062 Method of analyzing protein occurring in cell or substance interacting with the protein
11/25/2004	US20040235061 Using estimated breeding values as diagnostic prognosticators of disease resistance and sensitivity in animals; bioinformatics; animal husbandry
11/25/2004	US20040235060 Biosensor for defecting chemical agents
11/25/2004	US20040235059 Drug development and manufacturing
11/25/2004	US20040235055 Apparatus for monitoring/measuring changes receptors bound by target biological substance; secretion product sensor device; stress detector
11/25/2004	US20040235054 Novel encoding method for "one-bead one-compound" combinatorial libraries
11/25/2004	US20040235053 Preparation and application of encoded bead aggregates in combinatorial chemistry
11/25/2004	US20040235052 Using mass spectrometry to identify polypeptide patterns and to diagnose cancer, infections, cardiovascular and pregnancy disorders based on protein fingerprint
11/25/2004	US20040235051 Solid phase synthesis; microarrays
11/25/2004	US20040235049 Device for presentation of polypeptides able to be used as a chip for miniaturised detection of molecules

1 ... 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 2237 2238 2239 2240 2241 2242 2243 2244 2245 2246 ... 3937